Simoa Success Webinars: Covid-19 Focus
…second week of events in the series focused on the study of COVID-19, with presentations from current Simoa users who shared their data and experiences using our technology to advance…
read moreWe found 20 Results for "Valid H22-121_V1.0 Study Plan ☝ Valid H22-121_V1.0 Study Plan 💉 H22-121_V1.0 Latest Practice Questions 🍕 Search on ⏩ www.pdfvce.com ⏪ for ▛ H22-121_V1.0 ▟ to obtain exam materials for free download 🐁Dumps H22-121_V1.0 PDF"
…second week of events in the series focused on the study of COVID-19, with presentations from current Simoa users who shared their data and experiences using our technology to advance…
read more
Nature.com Webcasts 8AM PST | 11AM EST | 4PM GMT | 5PM CET Watch On Demand Compared to tissue-based biomarkers, blood-based biomarkers have many advantages including lower risks to patients,…
read more
…and their potential application in clinical contexts. A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelists. Speakers Andy Liu, MD,…
read more
…our key assays for Alzheimer’s Disease, including phosphorylated Tau and our multiplex assays. Most importantly, we answered questions from the audience on how a neuro-toolbox on Simoa® can help your…
read more
…in small volumes of blood or other common sample types, the Quanterix SP-X Imaging and Analysis System is helping researchers of infectious disease answer their most time-sensitive research questions with speed and precision. Access…
read more
…pTau217, pTau231, and other neurological biomarkers. This panel discussion and live Q and A will cover the latest developments and opportunities to impact AD clinical trials and diagnostics. The discussion…
read more
…and a study of the cellular source of IFNα protein indicated disease-specific mechanisms. Measurement of IFNα attomolar concentrations by digital ELISA is enhancing our understanding of IFN biology and potentially…
read more
…of Ramón y Cajal University Hospital discuss their recent work in the study of HIV and COVID-19, respectively, using Simoa technology. A Simoa expert panel is moderated by Laurel Provencher, PhD,…
read more
…study, for which Dr. Kuhle is the lead author, is the most comprehensive to date, examining 20,000 samples from a diverse set of donors that spanned different age groups and…
read more